This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alliança withdraws Brazil filing for Meddi deal after controlling shareholder’s exit

By Maria Júlia Baumert ( February 25, 2026, 19:07 GMT | Comment) -- A sudden and complex restructuring of Alliança Saúde’s ownership has derailed the company’s merger‑control process in Brazil for buying Grupo Meddi. While the authority signaled that the acquisition must be notified again if pursued in the future, Alliança has been careful to say there's no commitment to resubmit the deal –– a message embedded in its communications to the Securities and Exchange Commission of Brazil.A sudden and complex restructuring of Alliança Saúde’s ownership has derailed the company’s merger‑control process in Brazil for buying Grupo Meddi. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login